标题
Harnessing the immune system in glioblastoma
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 119, Issue 10, Pages 1171-1181
出版商
Springer Nature America, Inc
发表日期
2018-10-30
DOI
10.1038/s41416-018-0258-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
- (2018) Dipongkor Saha et al. CLINICAL CANCER RESEARCH
- First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1
- (2018) Michael A. Vogelbaum et al. JOURNAL OF NEUROSURGERY
- Driving T-cell immunotherapy to solid tumors
- (2018) Ken Garber NATURE BIOTECHNOLOGY
- The intestinal microbiome influences checkpoint blockade
- (2018) Cynthia L Sears et al. NATURE MEDICINE
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
- (2018) Franz L. Ricklefs et al. Science Advances
- Myeloid Cells in the Central Nervous System
- (2017) Jasmin Herz et al. IMMUNITY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunotherapy and radiation in glioblastoma
- (2017) Solmaz Sahebjam et al. JOURNAL OF NEURO-ONCOLOGY
- Bone marrow response as a potential biomarker of outcomes in glioblastoma patients
- (2017) Eugene J. Vaios et al. JOURNAL OF NEUROSURGERY
- Severe cerebral edema following nivolumab treatment for pediatric glioblastoma: case report
- (2017) Xiao Zhu et al. Journal of Neurosurgery-Pediatrics
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
- (2017) Michael Weller et al. LANCET ONCOLOGY
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Regulatory T cells promote myelin regeneration in the central nervous system
- (2017) Yvonne Dombrowski et al. NATURE NEUROSCIENCE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
- (2017) Antonio Omuro et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- New Directions in Anti-Angiogenic Therapy for Glioblastoma
- (2017) Nancy Wang et al. Neurotherapeutics
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
- (2017) Andrew S. Venteicher et al. SCIENCE
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
- (2017) Pengju Wang et al. Nature Communications
- Glioblastoma progression is assisted by induction of immunosuppressive function of pericytes through interaction with tumor cells
- (2017) Rut Valdor et al. Oncotarget
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Vascular, glial, and lymphatic immune gateways of the central nervous system
- (2016) Britta Engelhardt et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Toxicities of chimeric antigen receptor T cells: recognition and management
- (2016) Jennifer N. Brudno et al. BLOOD
- Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
- (2016) Aleksei A. Stepanenko et al. Cancer Cell International
- CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages
- (2016) I. De et al. CANCER RESEARCH
- Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity
- (2016) F. Ricklefs et al. CANCER RESEARCH
- Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future
- (2016) Ricky Chen et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Immunological effects of chemotherapy and radiotherapy against brain tumors
- (2016) Tobias Weiss et al. Expert Review of Anticancer Therapy
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Novel vaccines for glioblastoma: clinical update and perspective
- (2016) Evan K Winograd et al. Immunotherapy
- The extracellular matrix niche microenvironment of neural and cancer stem cells in the brain
- (2016) Jacqueline Reinhard et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival
- (2016) Soumi Kundu et al. MOLECULAR CANCER RESEARCH
- Emerging concepts of T cell metabolism as a target of immunotherapy
- (2016) Chih-Hao Chang et al. NATURE IMMUNOLOGY
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- ATIM-35. RESULTS OF THE PHASE IB KEYNOTE-028 MULTI-COHORT TRIAL OF PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT PD-L1-POSITIVE GLIOBLASTOMA MULTIFORME (GBM)
- (2016) David A. Reardon et al. NEURO-ONCOLOGY
- Tumor treating fields: a novel treatment modality and its use in brain tumors
- (2016) Andreas F. Hottinger et al. NEURO-ONCOLOGY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
- (2016) D. Mathios et al. Science Translational Medicine
- Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
- (2016) Anja Derer et al. Frontiers in Immunology
- Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors
- (2015) Susan Brandenburg et al. ACTA NEUROPATHOLOGICA
- Glioblastoma: pathology, molecular mechanisms and markers
- (2015) Kenneth Aldape et al. ACTA NEUROPATHOLOGICA
- Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
- (2015) E T Wong et al. BRITISH JOURNAL OF CANCER
- HER2 expression status in diverse cancers: review of results from 37,992 patients
- (2015) Min Yan et al. CANCER AND METASTASIS REVIEWS
- Extra-CNS metastasis from glioblastoma: a rare clinical entity
- (2015) Musaddiq Awan et al. Expert Review of Anticancer Therapy
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- IDO inhibitors move center stage in immuno-oncology
- (2015) Cormac Sheridan NATURE BIOTECHNOLOGY
- Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
- (2015) Wenchao Zhou et al. NATURE CELL BIOLOGY
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- The Glymphatic System: A Beginner’s Guide
- (2015) Nadia Aalling Jessen et al. NEUROCHEMICAL RESEARCH
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Harnessing the Microbiome to Enhance Cancer Immunotherapy
- (2015) Michelle H. Nelson et al. Journal of Immunology Research
- Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
- (2015) Sabrina Genßler et al. OncoImmunology
- Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy
- (2015) Jian Qiao et al. OncoImmunology
- Immunotherapeutic Advancements for Glioblastoma
- (2015) Leonel Ampie et al. Frontiers in Oncology
- Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites
- (2015) Powell Perng et al. Frontiers in Oncology
- Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro
- (2014) Christian Pieper et al. BRAIN RESEARCH
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
- (2014) S. J. Dovedi et al. CANCER RESEARCH
- Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma
- (2014) A. Schuessler et al. CANCER RESEARCH
- HER2 aberrations in cancer: Implications for therapy
- (2014) Min Yan et al. CANCER TREATMENT REVIEWS
- Metastatic Stem Cells: Sources, Niches, and Vital Pathways
- (2014) Thordur Oskarsson et al. Cell Stem Cell
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma
- (2014) Robert L Bowman et al. Immunotherapy
- Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
- (2014) Eiichi Ishikawa et al. JOURNAL OF NEUROSURGERY
- Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
- (2014) B. Thaci et al. NEURO-ONCOLOGY
- Immunotherapy advances for glioblastoma
- (2014) D. A. Reardon et al. NEURO-ONCOLOGY
- Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
- (2014) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Transforming growth factor-beta and its implication in the malignancy of gliomas
- (2014) Laurent-Olivier Roy et al. Targeted Oncology
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Does the Immune System Naturally Protect Against Cancer?
- (2014) Alexandre Corthay Frontiers in Immunology
- Convection-Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations
- (2013) Neil U. Barua et al. BRAIN PATHOLOGY
- Clinical significance of macrophage heterogeneity in human malignant tumors
- (2013) Yoshihiro Komohara et al. CANCER SCIENCE
- Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
- (2013) O. Bloch et al. CLINICAL CANCER RESEARCH
- Efficiently stimulated adult microglia cross-prime naive CD8+T cells injected in the brain
- (2013) Ulrich Jarry et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Proteoglycans and their roles in brain cancer
- (2013) Anna Wade et al. FEBS Journal
- Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
- (2013) Vidyalakshmi Chandramohan et al. Future Oncology
- Immune system: a double-edged sword in cancer
- (2013) Bodduluru Lakshmi Narendra et al. INFLAMMATION RESEARCH
- Bystander effects in tumor-free and tumor-bearing rat brains following irradiation by synchrotron X-rays
- (2013) Cristian Fernandez-Palomo et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes
- (2013) Jon D. Laman et al. Journal of Neuroimmune Pharmacology
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- The upregulation of programmed death 1 on peripheral blood T cells of glioma is correlated with disease progression
- (2013) Bo Wei et al. TUMOR BIOLOGY
- Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
- (2013) T. Doucette et al. Cancer Immunology Research
- Adoptive Cell Therapies for Glioblastoma
- (2013) Kevin Bielamowicz et al. Frontiers in Oncology
- Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
- (2012) Karsten Geletneky et al. BMC CANCER
- Oncolytic Virus Therapy for Glioblastoma Multiforme
- (2012) Guido Wollmann et al. CANCER JOURNAL
- Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF- 1 Signaling Pathway
- (2012) X.-z. Ye et al. JOURNAL OF IMMUNOLOGY
- Macrophage plasticity and polarization in tissue repair and remodelling
- (2012) Alberto Mantovani et al. JOURNAL OF PATHOLOGY
- Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus
- (2012) Hiroaki Uchida et al. MOLECULAR THERAPY
- Irradiation Promotes an M2 Macrophage Phenotype in Tumor Hypoxia
- (2012) Chi-Shiun Chiang et al. Frontiers in Oncology
- Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis
- (2011) Vivian F. Zhu et al. CANCER LETTERS
- Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
- (2011) Christopher Jackson et al. Clinical & Developmental Immunology
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
- (2011) Stuart A. Grossman et al. CLINICAL CANCER RESEARCH
- Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
- (2011) Camilo E. Fadul et al. JOURNAL OF IMMUNOTHERAPY
- MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism
- (2011) Mathias F Leber et al. MOLECULAR THERAPY
- Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
- (2011) C. E. Fadul et al. NEURO-ONCOLOGY
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
- (2010) T. Di Tomaso et al. CLINICAL CANCER RESEARCH
- Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme
- (2010) Mizuhiko Terasaki et al. JOURNAL OF CLINICAL ONCOLOGY
- Extracellular Matrix of Glioblastoma Inhibits Polarization and Transmigration of T Cells: The Role of Tenascin-C in Immune Suppression
- (2010) J.-Y. Huang et al. JOURNAL OF IMMUNOLOGY
- Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?
- (2010) A. B. Heimberger et al. NEURO-ONCOLOGY
- Development of Monocytes, Macrophages, and Dendritic Cells
- (2010) F. Geissmann et al. SCIENCE
- Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model
- (2009) T.-G. Kim et al. Clinical and Vaccine Immunology
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
- (2008) Y Komohara et al. JOURNAL OF PATHOLOGY
- Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
- (2008) Joannes F.M. Jacobs et al. NEURO-ONCOLOGY
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
- (2007) Duane A. Mitchell et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now